Union Calendar No. 451
116th CONGRESS 2d Session |
[Report No. 116–551]
To amend the Federal Food, Drug, and Cosmetic Act to make permanent the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.
September 20, 2019
Mr. Butterfield (for himself, Mr. McCaul, Ms. Speier, Mr. Kelly of Pennsylvania, Mr. Engel, Mr. Bilirakis, Ms. Kelly of Illinois, Mr. Hudson, Mr. Rush, and Mr. Mullin) introduced the following bill; which was referred to the Committee on Energy and Commerce
September 29, 2020
Additional sponsors: Mr. Fitzpatrick, Ms. DeGette, Mrs. Rodgers of Washington, Mrs. Luria, Mr. Rutherford, Mr. Carson of Indiana, Mr. Rodney Davis of Illinois, Ms. Clarke of New York, Ms. Blunt Rochester, Ms. Barragán, Mr. Soto, Mr. Cárdenas, Ms. Kuster of New Hampshire, Mr. Griffith, Mr. Carter of Georgia, Mr. Marshall, Mr. Cohen, Mr. Woodall, Mr. DeFazio, Mr. Balderson, Mr. Malinowski, Mr. Brooks of Alabama, Ms. Lofgren, Mr. King of Iowa, Ms. Porter, Mr. Marchant, Mr. McEachin, Mr. DeSaulnier, Mrs. Lesko, Mr. Fortenberry, Ms. Bonamici, Ms. Sherrill, and Mr. Wilson of South Carolina
September 29, 2020
Reported with amendments; committed to the Committee of the Whole House on the State of the Union and ordered to be printed
[Strike out all after the enacting clause and insert the part printed in italic]
[For text of introduced bill, see copy of bill as introduced September 20, 2019]
To amend the Federal Food, Drug, and Cosmetic Act to make permanent the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SEC. 2. Extension of authority to issue priority review vouchers to encourage treatments for rare pediatric diseases.
Section 529(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360ff(b)) is amended—
Amend the title so as to read: “A bill to amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.”.
Union Calendar No. 451 | |||||
| |||||
[Report No. 116–551] | |||||
A BILL | |||||
To amend the Federal Food, Drug, and Cosmetic Act to make permanent the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases. | |||||
September 29, 2020 | |||||
Reported with amendments; committed to the Committee of the Whole House on the State of the Union and ordered to be printed |